View in EDS PDF Full Text

Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination.

Saved in:
Bibliographic Details
Title: Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination.
Authors: Davis C; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom., Logan N; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom., Tyson G; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom., Orton R; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom., Harvey WT; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom., Perkins JS; Clinical Research Facility, Queen Elizabeth University Hospital, Glasgow, United Kingdom., Mollett G; Clinical Research Facility, Queen Elizabeth University Hospital, Glasgow, United Kingdom., Blacow RM; Clinical Research Facility, Queen Elizabeth University Hospital, Glasgow, United Kingdom., Peacock TP; Department of Infectious Disease, Imperial College London, London, United Kingdom., Barclay WS; Department of Infectious Disease, Imperial College London, London, United Kingdom., Cherepanov P; The Francis Crick Institute, London, United Kingdom., Palmarini M; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom., Murcia PR; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom., Patel AH; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom., Robertson DL; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom., Haughney J; Clinical Research Facility, Queen Elizabeth University Hospital, Glasgow, United Kingdom., Thomson EC; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom.; Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, United Kingdom., Willett BJ; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom.
Corporate Authors: COVID-19 Genomics UK (COG-UK) Consortium, COVID-19 DeplOyed VaccinE (DOVE) Cohort Study investigators
Source: PLoS pathogens [PLoS Pathog] 2021 Dec 02; Vol. 17 (12), pp. e1010022. Date of Electronic Publication: 2021 Dec 02 (Print Publication: 2021).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34855916
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Davis+C%22">Davis C</searchLink>; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Logan+N%22">Logan N</searchLink>; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Tyson+G%22">Tyson G</searchLink>; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Orton+R%22">Orton R</searchLink>; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Harvey+WT%22">Harvey WT</searchLink>; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Perkins+JS%22">Perkins JS</searchLink>; Clinical Research Facility, Queen Elizabeth University Hospital, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Mollett+G%22">Mollett G</searchLink>; Clinical Research Facility, Queen Elizabeth University Hospital, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Blacow+RM%22">Blacow RM</searchLink>; Clinical Research Facility, Queen Elizabeth University Hospital, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Peacock+TP%22">Peacock TP</searchLink>; Department of Infectious Disease, Imperial College London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Barclay+WS%22">Barclay WS</searchLink>; Department of Infectious Disease, Imperial College London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Cherepanov+P%22">Cherepanov P</searchLink>; The Francis Crick Institute, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Palmarini+M%22">Palmarini M</searchLink>; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Murcia+PR%22">Murcia PR</searchLink>; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Patel+AH%22">Patel AH</searchLink>; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Robertson+DL%22">Robertson DL</searchLink>; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Haughney+J%22">Haughney J</searchLink>; Clinical Research Facility, Queen Elizabeth University Hospital, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Thomson+EC%22">Thomson EC</searchLink>; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom.; Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Willett+BJ%22">Willett BJ</searchLink>; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, United Kingdom.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22COVID-19+Genomics+UK+%28COG-UK%29+Consortium%22">COVID-19 Genomics UK (COG-UK) Consortium</searchLink><br /><searchLink fieldCode="CA" term="%22COVID-19+DeplOyed+VaccinE+%28DOVE%29+Cohort+Study+investigators%22">COVID-19 DeplOyed VaccinE (DOVE) Cohort Study investigators</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101238921%22">PLoS pathogens</searchLink> [PLoS Pathog] 2021 Dec 02; Vol. 17 (12), pp. e1010022. <i>Date of Electronic Publication: </i>2021 Dec 02 (<i>Print Publication: </i>2021).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101238921 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1553-7374 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215537366%22">15537366 </searchLink><i>NLM ISO Abbreviation: </i>PLoS Pathog <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34855916
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1371/journal.ppat.1010022
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e1010022
    Titles:
      – TitleFull: Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Davis C
      – PersonEntity:
          Name:
            NameFull: Logan N
      – PersonEntity:
          Name:
            NameFull: Tyson G
      – PersonEntity:
          Name:
            NameFull: Orton R
      – PersonEntity:
          Name:
            NameFull: Harvey WT
      – PersonEntity:
          Name:
            NameFull: Perkins JS
      – PersonEntity:
          Name:
            NameFull: Mollett G
      – PersonEntity:
          Name:
            NameFull: Blacow RM
      – PersonEntity:
          Name:
            NameFull: Peacock TP
      – PersonEntity:
          Name:
            NameFull: Barclay WS
      – PersonEntity:
          Name:
            NameFull: Cherepanov P
      – PersonEntity:
          Name:
            NameFull: Palmarini M
      – PersonEntity:
          Name:
            NameFull: Murcia PR
      – PersonEntity:
          Name:
            NameFull: Patel AH
      – PersonEntity:
          Name:
            NameFull: Robertson DL
      – PersonEntity:
          Name:
            NameFull: Haughney J
      – PersonEntity:
          Name:
            NameFull: Thomson EC
      – PersonEntity:
          Name:
            NameFull: Willett BJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 12
              Text: 2021 Dec 02
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1553-7374
          Numbering:
            – Type: volume
              Value: 17
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: PLoS pathogens
              Type: main
ResultId 1